Filing Impact
Filing Sentiment
Form Type
SCHEDULE 13G
Allogene Therapeutics
257.38M
152.19M
17.45%
74.07%
11.18%
Biotechnology
Biological Products, (no Disgnostic Substances)
United States
SOUTH SAN FRANCISCO